CCMD
AGN

Cypress Capital Management (Delaware)’s Allergan plc AGN Stock Holding History

Cypress Capital Management (Delaware)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-935
Closed -$284K – 75
2015
Q2 		$284K Sell
935
-100
-10% -$29.8K 0.08% 57
2015
Q1 		$308K Buy
1,035
+200
+24% +$57K 0.09% 57
2014
Q4 		$215K Buy
+835
New +$209K 0.06% 63
2014
Q3 		– Sell
-1,000
Closed -$223K – 59
2014
Q2 		$223K Hold
1,000
– – 0.07% 47
2014
Q1 		$206K Buy
+1,000
New +$198K 0.06% 46

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Cypress Capital Management (Delaware)'s AGN Position: Q3 2015 in Review

Cypress Capital Management (Delaware) sold out of Allergan plc (AGN) in Q3 2015, closing a stake of 935 shares — an estimated $284K sold.

Cypress Capital Management (Delaware) first reported a position in AGN in Q1 2014 and held it in 5 quarters. The position peaked at $308K in Q1 2015. 1,056 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • Cypress Capital Management (Delaware) reported no remaining Allergan plc position as of Q3 2015 after selling out during the quarter.
  • Cypress Capital Management (Delaware) sold 935 Allergan plc shares in Q3 2015, an estimated $284K.
  • Cypress Capital Management (Delaware) first reported a position in Allergan plc in Q1 2014 and held it in 5 quarters.
  • Cypress Capital Management (Delaware)'s Allergan plc position peaked at $308K in Q1 2015.
  • 1,056 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q3 2015, filed 9 Nov 2015.